Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide
(Q40687579)
scientific article published on November 2002
scientific article published on November 2002
Language:
Current Data About
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide
other details
description | scientific article published on November 2002 |
External Links
(P356) |
10.1023/A:1020543004400
|
(P698) |
12452453
|
(P6179) |
1010640749
|